相关产品推荐更多 >

PE标记小鼠抗猪CD4a抗体 | Mouse Anti-Porcine CD4a-PE
询价![CD282 抗体 [TL2.1] (FITC)-CD282 Antibody [TL2.1] (FITC)](https://img1.dxycdn.com/p/s14/2023/1219/544/2992103923597007371.jpg!wh200)
CD282 抗体 [TL2.1] (FITC)-CD282 Antibody [TL2.1] (FITC)
¥22
PacBlue Anti-human CD138 Antibody *MI15*/PacBlue Anti-human CD138 Antibody *MI15*/PacBlue Anti-human CD138 Antibody *MI15*
询价
Zinc Finger Protein 660 (ZNF660) Antibody/Zinc Finger Protein 660 (ZNF660) Antibody/Zinc Finger Protein 660 (ZNF660) Antibody
询价
BCL2单克隆抗体, 克隆号Bcl2/100 | BCL2 monoclonal antibody, clone Bcl2/100
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Human isolate, type 3
- 保存条件:
stored at -20℃, stable for one year
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 宿主:
山羊
- 应用范围:
WB
- 抗体英文名:
Parainfluenza virus, type 3 Antibody
- 抗体名:
Parainfluenza virus, type 3 Antibody
- 规格:
0.05mL
Parainfluenza virus, type 3 抗体,Parainfluenza virus, type 3 Antibody,Parainfluenza virus, type 3 抗体,Parainfluenza virus, type 3 Antibody
产品名称:Parainfluenza virus, type 3 抗体-Parainfluenza virus, type 3 Antibody
产品货号:PSI-35-333-0.05mL
产品规格:0.05mL
背景资料:
保存建议:Parainfluenza virus, type 3 抗体-Parainfluenza virus, type 3 Antibody stored at -20℃, stable for one year
应用类型:WB
点击:Parainfluenza virus, type 3 抗体-Parainfluenza virus, type 3 Antibody查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验人类疱疹病毒6型(human herpes virus type 6,hhv-6)
人类疱疹病毒 6 型( human herpes virus type 6,hhv-6 )是 1986 年从淋巴增殖异常患者及爱滋病病人外周血单细胞首先分离到一种具有疱疹病毒形态和嗜淋巴细胞的新病毒,它志疱疹病毒科其他 5 个型病毒的抗原性和酶切图谱不同,故名 hhv-6 。 人类感染 hhv-6 十分普遍,但多为隐性感染。免疫荧光试验可在 60 ~ 80% 儿童及成人血清中查到 hhv-6 抗体。 hhv-6 是婴儿急疹(玫瑰
The BB Rat as a Model of Human Type 1 Diabetes
The BB rat is an important rodent model of human type 1 diabetes (T1D) and has been used to study mechanisms of diabetes pathogenesis as well as to investigate potential intervention therapies for clinical trials. The Diabetes-Prone BB (BBDP
Virus-like Particles As Vaccine Adjuvants
. This can be done by expressing the antigen inside the APC, using a DNA vaccine or recombinant virus. DNA vaccines can be produced easily, but there are still concerns over the long-term safety of this new type of vaccine, and the CD8+ T-cell response may only be moderate
技术资料暂无技术资料 索取技术资料






